Osteoporosis, diabetes, and hypertension are major risk factors for mortality in older adults: an intermediate report on a prospective survey of 1467 community-dwelling elderly healthy pensioners in Switzerland

Abstract

BackgroundOsteoporosis is an important morbidity factor for ageing populations in developed countries. However, compared to the amount of information available on diabetes and cardiovascular disease, little is known about the direct impact of osteoporosis on general mortality in older age.MethodsWe obtained data from a prospective population-based cohort of pensioners from the SENIORLAB study who were subjectively healthy. The inclusion criteria were an age of at least 60 years and Swiss residence. We assessed and analysed clinical measures, voluntary reports, and laboratory values.ResultsIn total, 1467 subjects were included in the cohort. The mean follow-up time was 3.68 years (95% confidence interval, 3.64–3.71). The ages of the included participants ranged from 60 to 99 years. At follow-up, there were 1401 survivors, and 66 participants had died. According to the multivariate analysis (Cox regression), osteoporosis was the most important risk factor for all-cause mortality (hazard ratio, 4.46; 95% confidence interval, 1.82–10.91), followed by diabetes (hazard ratio, 2.17; 95% confidence interval, 1.04–4.52) and hypertension (hazard ratio, 1.81; 95% confidence interval, 1.09–3.03).ConclusionsOsteoporosis is a major risk factor for all-cause mortality in a subjectively healthy senior population, followed by type 2 diabetes mellitus and hypertension. Osteoporosis should be more actively diagnosed in healthy pensioners before they develop osteoporosis-associated health incidents.Trial registrationThe present study was registered in the International Standard Randomized Controlled Trial Number registry: ISRCTN53778569.

Elementary Laboratory Assays as Biomarkers of Ageing: Support for Treatment of COVID-19?

“…Ideal biomarkers should be able to predict individual age-specific mortality and age-associated pathology in addition to and better than chronological age alone, and they should serve as metrics and risk factors [ 83 , 85 ]. Such requirements also reflect challenges in choosing the right biomarkers.…”

Association of vitamin D receptor gene polymorphism with the occurrence of low bone density, osteopenia, and osteoporosis in patients with type 2 diabetes

“…Diabetes, osteoporosis, and vitamin D deficiency are common [1][2][3] and interrelated [4,5], globally. Osteoporosis and type 2 diabetes (T2D) are among the major risk factors of deaths in any population [6]. The impact of genetic and environmental factors on these outcomes has been previously demonstrated [7][8][9].…”

A novel quantitative method for estimating bone mineral density using B‑mode ultrasound and radiofrequency signals‑a pilot study on patients with rheumatoid arthritis

“…In an aging European population, osteoporosis has become a major public health problem. It increases morbidity and mortality (1–3) and it leads to high direct and indirect medical costs (4,5) for society due to its hallmark clinical manifestation: Fragility fractures, particularly vertebral and hip fractures. The population at risk includes post-menopausal females, the elderly, patients with long-term glucocorticoid treatment and patients with chronic inflammatory diseases, e.g.…”